MEDPLUS HEALTH SERVICES
Quarterly Results Analysis [Dec2023]
MEDPLUS HEALTH SERVICES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,441 Cr | ₹1,409 Cr | ₹1,284 Cr | ₹1,253 Cr | ₹1,190 Cr | ₹1,121 Cr | ₹994 Cr | ₹966 Cr |
Expenses | ₹1,350 Cr | ₹1,323 Cr | ₹1,213 Cr | ₹1,171 Cr | ₹1,119 Cr | ₹1,061 Cr | ₹941 Cr | ₹914 Cr |
Operating Income | ₹92 Cr | ₹85 Cr | ₹71 Cr | ₹82 Cr | ₹72 Cr | ₹60 Cr | ₹53 Cr | ₹52 Cr |
Other Income | ₹10 Cr | ₹10 Cr | ₹9 Cr | ₹14 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹13 Cr |
Interest | ₹24 Cr | ₹24 Cr | ₹23 Cr | ₹22 Cr | ₹21 Cr | ₹20 Cr | ₹20 Cr | ₹19 Cr |
Depreciation | ₹57 Cr | ₹55 Cr | ₹52 Cr | ₹56 Cr | ₹46 Cr | ₹42 Cr | ₹38 Cr | ₹34 Cr |
Profit Before Tax | ₹20 Cr | ₹16 Cr | ₹5 Cr | ₹17 Cr | ₹16 Cr | ₹9 Cr | ₹5 Cr | ₹13 Cr |
Profit After Tax | ₹14 Cr | ₹15 Cr | ₹4 Cr | ₹27 Cr | ₹13 Cr | ₹6 Cr | ₹4 Cr | ₹11 Cr |
EPS | ₹1.15 | ₹1.22 | ₹0.32 | ₹2.23 | ₹1.12 | ₹0.55 | ₹0.27 | ₹0.98 |
Industry Peers & Returns | 1W | 1M | 1Y |
MEDPLUS HEALTH SERVICES | -0% | -0.8% | -9.7% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
MEDPLUS HEALTH SERVICES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 2.33 % |
Y-o-Y | 21.10 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹1,441 Cr | 2.33 | |
Sep2023 | ₹1,409 Cr | 9.68 | |
Jun2023 | ₹1,284 Cr | 2.50 | |
Mar2023 | ₹1,253 Cr | 5.26 | |
Dec2022 | ₹1,190 Cr | 6.22 | |
Sep2022 | ₹1,121 Cr | 12.78 | |
Jun2022 | ₹994 Cr | 2.87 | |
Mar2022 | ₹966 Cr | - |
MEDPLUS HEALTH SERVICES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 7.86 % |
Y-o-Y | 27.96 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹92 Cr | 7.86 | |
Sep2023 | ₹85 Cr | 19.27 | |
Jun2023 | ₹71 Cr | -12.60 | |
Mar2023 | ₹82 Cr | 13.81 | |
Dec2022 | ₹72 Cr | 20.21 | |
Sep2022 | ₹60 Cr | 13.34 | |
Jun2022 | ₹53 Cr | 0.71 | |
Mar2022 | ₹52 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 5.46 % |
Y-o-Y | 5.64 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 6.37% | 5.46 | |
Sep2023 | 6.04% | 8.63 | |
Jun2023 | 5.56% | -14.59 | |
Mar2023 | 6.51% | 7.96 | |
Dec2022 | 6.03% | 13.35 | |
Sep2022 | 5.32% | 0.38 | |
Jun2022 | 5.3% | -2.03 | |
Mar2022 | 5.41% | - |
MEDPLUS HEALTH SERVICES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -5.77 % |
Y-o-Y | 2.42 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹14 Cr | -5.77 | |
Sep2023 | ₹15 Cr | 286.29 | |
Jun2023 | ₹4 Cr | -85.82 | |
Mar2023 | ₹27 Cr | 98.48 | |
Dec2022 | ₹13 Cr | 106.56 | |
Sep2022 | ₹6 Cr | 76.08 | |
Jun2022 | ₹4 Cr | -67.81 | |
Mar2022 | ₹11 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -7.77 % |
Y-o-Y | -15.18 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 0.95 % | -7.77 | |
Sep2023 | 1.03 % | 255.17 | |
Jun2023 | 0.29 % | -86.32 | |
Mar2023 | 2.12 % | 89.29 | |
Dec2022 | 1.12 % | 93.10 | |
Sep2022 | 0.58 % | 56.76 | |
Jun2022 | 0.37 % | -68.64 | |
Mar2022 | 1.18 % | - |
MEDPLUS HEALTH SERVICES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -5.74 % |
Y-o-Y | 2.68 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹1.15 | -5.74 | |
Sep2023 | ₹1.22 | 281.25 | |
Jun2023 | ₹0.32 | -85.65 | |
Mar2023 | ₹2.23 | 99.11 | |
Dec2022 | ₹1.12 | 103.64 | |
Sep2022 | ₹0.55 | 103.70 | |
Jun2022 | ₹0.27 | -72.45 | |
Mar2022 | ₹0.98 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD